Condition
Congenital Dyserythropoietic Anemia (CDA)
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Recruiting3
Clinical Trials (3)
Showing 3 of 3 trials
NCT07471516Phase 1RecruitingPrimary
Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia
NCT07206095Recruiting
Integrative Diagnosis for SCD and Other RADs
NCT02964494RecruitingPrimary
The Congenital Dyserythropoietic Anemia Registry (CDAR)
Showing all 3 trials